RE: RE: RE: Setting up well- AEZA 4 to 6 IPSS score improvement is consistent with past studies where the Placebo effect has been present. There may be no Placebo effect but if there is expect up to a 6 point improvement. PRX has interest coming at them from major pharma in the US, Europe and Japan. Good Phase 2b results puts Fahar in the drivers seat. This product could easily replace a number of the oral drugs on the market. Flowmax does euro$1.3 billion per year in sales for Boehringer Ingelheim. You can bet they are watching this very closely. Not to mention that the results PRX showed in Phase 2a are consistent with the results from surgical procedures with out the recovery period or side effects. In the world of BPH this is big.